Dr Julian Barwell trained in Medicine at Guy's and St Thomas' Hospitals in London (1991-1997: Distinction in Medicine and intercalated BSc in Basic Medical Sciences and Human Genetics). He was a junior doctor in South London and became a Member of the Royal College of Physicians in 2000. He completed his PhD in familial breast cancer susceptibility in 2006. After finishing his Clinical Genetics training (2001-2007) at Guy's, St George's and the Royal Marsden from the University of London; he started as a consultant in Clinical Genetics in Leicester. He was the senior editor of the Royal College of Physicians five yearly update in Clinical Genetics in 2014 and is a senior author of the newly commissioned book Clinical Genetics at a Glance. He has been voted onto the United Kingdom Cancer Genetics Group Steering Committee and was awarded an honorary chair (professorship) by the University of Leicester in 2015

Barwell. Review of Cancer Genomics 2007 Human Genetics 2008 Barwell et al. Is telomere length in peripheral blood lymphocytes correlated with cancer susceptibility or radiosensitivity? Brit J of Cancer 2007 Barwell et al. Chromosome breakage in BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2007 Oct 1;121(7):1631-6 Barwell et al. Cellular phenotype in MSH2 homozygous mutation carrier. J Med Genet. 2007 Aug;44(8):516-20 Georgiou et al. Is chromosome radiosensitivity and apoptotic response to irradiation correlated with cancer susceptibility? Int J Radiat Biol. 2007 Jan;83(1):1-12 Pollard et al. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. J Clin Endocrinol Metab. 2006; 91(11):4593-8. Brinkman et al. Evidence against a major genetic basis for combined breast and colorectal cancer susceptibility. Clin Genet. 2006. 70(6):526-9. Geary et al. The management of families affected by hereditary non-polyposis colon cancer (HNPCC) Fam Cancer. 2006 2007;6(1):13-9. Pollard et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet. 2005 Aug 1;14(15):2231-9. Pollard et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours, which result from germline FH and SDH mutations. Hum Mol Genet 2005 14(15):2231-9. Leegte et al. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. J Med Genet 2005 42(3):e20.